Free Disclosure Statement - District Court of Delaware - Delaware

Case 1:07-cv-00572-GMS

Document 54

Filed 11/05/2007

Page 1 of 2

IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE : : : : : Plaintiffs, : : v. : : ACTAVIS SOUTH ATLANTIC LLC, : AUROBINDO PHARMA LTD., : AUROBINDO PHARMA USA INC., : MYLAN PHARMACEUTICALS INC., : PAR PHARMACEUTICAL, INC., : RANBAXY INC., RANBAXY : LABORATORIES LIMITED, SUN PHARMACEUTICAL INDUSTRIES, INC., : SUN PHARMACEUTICAL INDUSTRIES : LTD, TEVA PHARMACEUTICALS USA, : : INC., TORRENT PHARMA INC. and : TORRENT PHARMACEUTICALS : LIMITED, : : Defendants. SANOFI-AVENTIS and SANOFI-AVENTIS U.S. LLC,

CIVIL ACTION NO. 07-572 GMS

CORPORATE DISCLOSURE STATEMENT PURSUANT TO RULE 7.1 OF AUROBINDO PHARMA USA INC. Pursuant to Rule 7.1 of the Federal Rules of Civil Procedure, Defendant Aurobindo Pharma USA Inc. hereby states that it is a wholly-owned subsidiary of Aurobindo Pharma Ltd., an Indian corporation. No publicly held company owns 10% or more of Aurobindo Pharma Ltd.'s stock.

Case 1:07-cv-00572-GMS

Document 54

Filed 11/05/2007

Page 2 of 2

Dated: November 5, 2007.

Respectfully submitted, AUROBINDO PHARMA LTD.

By:

/s/ Mary B. Matterer Mary B. Matterer (I.D. No. 2696) MORRIS JAMES LLP 500 Delaware Ave., Ste. 1500 Wilmington, DE 19801 Telephone: (302) 888-6800 Facsimile: (302) 571-1750 [email protected]

Of Counsel (pro hac vice): Christine J. Siwik Paul J. Molino Deanne M. Mazzochi RAKOCZY MOLINO MAZZOCHI SIWIK LLP 6 West Hubbard Street, Suite 500 Chicago, Illinois 60610 Telephone: (312) 527-2157 Facsimile: (312) 527-4205 Attorneys for Defendant Aurobindo Pharma Ltd.

2